Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Anti-inflammatory Drugs Market: By Indication, Multiple Sclerosis, Inflammatory Bowel Disease, Psoriatic Arthritis, Gout), By Drug Type, Corticosteroids, Biologics, Immune Selective Anti-Inflammatory Derivatives ), By Formulation By Distribution Channel and Geography
Anti-inflammatory Drugs Market size was valued at US$ 104.6 billion in 2023 and is poised to grow at a CAGR of 9.2% from 2024 - 2030. described by the nearness of driving players. The players in the market are to a great extent concentrating on the advancement of biologicals, which have less reactions and better adequacy. In spite of the fact that biologics are costly, their improved wellbeing and adequacy will enable sellers to get a bigger offer of the market once launched. The ascend in key partnerships by merchants is one of the most recent patterns that will pick up footing in the anti-inflammatory therapeutics market in the coming years. The anti-inflammatory therapeutics market is right now an expansion in the procurement of anti-inflammatory therapeutics by significant merchants. For example, one of the main player Pfizer as of late obtained Anacor Pharmaceuticals.
This helped Pfizer pick up the business rights for Anacor Pharmaceuticals' crisaborole, a non-steroidal topical PDE-4 inhibitor with anti-inflammatory properties, which was endorsed by the US FDA. Anti-inflammatory alludes to the property of a substance or treatment that diminishes irritation or swelling. The anti-inflammatory drugs Market make up about the portion of analgesics, curing torment by decreasing aggravation instead of opioids, which influence the focal sensory system to square torment motioning to the brain. Anti-inflammatory drugs are utilized to treat joint inflammation, sprains, excruciating periods and other difficult conditions. The vast majority experience no difficulty taking these tablets. In any case, a few people create symptoms which can now and again be not kidding. Specifically - on the off chance that you have any cardiovascular (heart, stroke, or vein) condition or certain gut conditions, or are elderly, these drugs are endorsed with alert and just where there are no choices and at the most minimal measurements and terms vital.
Study Period
2024-2030Base Year
2023CAGR
9.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The worldwide anti-inflammatory market has been driven by variables, for example, expanding the immune system and respiratory diseases, new medications in pipeline and expanding the adoption of anti-inflammatory drugs. The interest for anti-inflammatory drugs has been expanding inferable from the rise of anti-inflammatory biologics that are more focused on, viable and with lesser symptoms when contrasted with traditional medications. Additionally, expanding familiarity with anti-inflammatory market therapeutics and alluring government activities in the Asia-Pacific and LAMEA area are relied upon to drive the market amid the investigation time frame. Factors such as symptoms of anti-inflammatory medications and patent expiry issues of blockbuster drugs, (for example, Remicade), are known to hinder the market development.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 104.6 billion |
Market CAGR |
9.2% |
By Application |
|
By Drug Class |
|
By Formulations |
|
By End User |
|
Download Free Sample Report
The anti-inflammatory drugs market size was valued at US$ 104.6 billion in 2023
The anti-inflammatory drugs market key players are: Allergan, Inc. (S.) AbbVie Inc., (U.S.) Takeda Pharmaceutical Company Limited (Japan) Bayer AG (Switzerland) Pfizer Inc. (US) Reddys (India) Novartis (Switzerland) Sanofi Avemtis (France) Eli Lilly (US)
The anti-inflammatory drugs market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Anti-inflammatory Drugs Market Introduction |
2.1.Global Anti-inflammatory Drugs Market - Taxonomy |
2.2.Global Anti-inflammatory Drugs Market - Definitions |
2.2.1.Application |
2.2.2.Drug Class |
2.2.3.Formulations |
2.2.4.End User |
2.2.5.Region |
3. Global Anti-inflammatory Drugs Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Anti-inflammatory Drugs Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Anti-inflammatory Drugs Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Rheumatoid Arthritis |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Chronic Obstructive Pulmonary Disease (COPD) |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Multiple Sclerosis |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Inflammatory Bowel Disease (IBD) |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Psoriatic Arthritis |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Gout |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. Global Anti-inflammatory Drugs Market By Drug Class, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Corticosteroids |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Biologics |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Immune Selective Anti-Inflammatory Derivatives (ImSAIDs) |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Anti-inflammatory Drugs Market By Formulations, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Oral |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Parenteral |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Topical |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Anti-inflammatory Drugs Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Hospital Pharmacy |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Clinics |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Online Pharmacy |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Retail Pharmacy |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9.Global Anti-inflammatory Drugs Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America Anti-inflammatory Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Rheumatoid Arthritis |
10.1.2.Chronic Obstructive Pulmonary Disease (COPD) |
10.1.3.Multiple Sclerosis |
10.1.4.Inflammatory Bowel Disease (IBD) |
10.1.5.Psoriatic Arthritis |
10.1.6.Gout |
10.2. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
10.2.2.Corticosteroids |
10.2.3.Biologics |
10.2.4.Immune Selective Anti-Inflammatory Derivatives (ImSAIDs) |
10.3. Formulations Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Oral |
10.3.2.Parenteral |
10.3.3.Topical |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospital Pharmacy |
10.4.2.Clinics |
10.4.3.Online Pharmacy |
10.4.4.Retail Pharmacy |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Anti-inflammatory Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Rheumatoid Arthritis |
11.1.2.Chronic Obstructive Pulmonary Disease (COPD) |
11.1.3.Multiple Sclerosis |
11.1.4.Inflammatory Bowel Disease (IBD) |
11.1.5.Psoriatic Arthritis |
11.1.6.Gout |
11.2. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
11.2.2.Corticosteroids |
11.2.3.Biologics |
11.2.4.Immune Selective Anti-Inflammatory Derivatives (ImSAIDs) |
11.3. Formulations Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Oral |
11.3.2.Parenteral |
11.3.3.Topical |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospital Pharmacy |
11.4.2.Clinics |
11.4.3.Online Pharmacy |
11.4.4.Retail Pharmacy |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) Anti-inflammatory Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Rheumatoid Arthritis |
12.1.2.Chronic Obstructive Pulmonary Disease (COPD) |
12.1.3.Multiple Sclerosis |
12.1.4.Inflammatory Bowel Disease (IBD) |
12.1.5.Psoriatic Arthritis |
12.1.6.Gout |
12.2. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
12.2.2.Corticosteroids |
12.2.3.Biologics |
12.2.4.Immune Selective Anti-Inflammatory Derivatives (ImSAIDs) |
12.3. Formulations Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Oral |
12.3.2.Parenteral |
12.3.3.Topical |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospital Pharmacy |
12.4.2.Clinics |
12.4.3.Online Pharmacy |
12.4.4.Retail Pharmacy |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Anti-inflammatory Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Rheumatoid Arthritis |
13.1.2.Chronic Obstructive Pulmonary Disease (COPD) |
13.1.3.Multiple Sclerosis |
13.1.4.Inflammatory Bowel Disease (IBD) |
13.1.5.Psoriatic Arthritis |
13.1.6.Gout |
13.2. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
13.2.2.Corticosteroids |
13.2.3.Biologics |
13.2.4.Immune Selective Anti-Inflammatory Derivatives (ImSAIDs) |
13.3. Formulations Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Oral |
13.3.2.Parenteral |
13.3.3.Topical |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospital Pharmacy |
13.4.2.Clinics |
13.4.3.Online Pharmacy |
13.4.4.Retail Pharmacy |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America Anti-inflammatory Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Rheumatoid Arthritis |
14.1.2.Chronic Obstructive Pulmonary Disease (COPD) |
14.1.3.Multiple Sclerosis |
14.1.4.Inflammatory Bowel Disease (IBD) |
14.1.5.Psoriatic Arthritis |
14.1.6.Gout |
14.2. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
14.2.2.Corticosteroids |
14.2.3.Biologics |
14.2.4.Immune Selective Anti-Inflammatory Derivatives (ImSAIDs) |
14.3. Formulations Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Oral |
14.3.2.Parenteral |
14.3.3.Topical |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospital Pharmacy |
14.4.2.Clinics |
14.4.3.Online Pharmacy |
14.4.4.Retail Pharmacy |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Allergan, Inc. (S.) |
15.2.2.AbbVie Inc., (U.S.) |
15.2.3.Takeda Pharmaceutical Company Limited (Japan) |
15.2.4.Bayer AG (Switzerland) |
15.2.5.Pfizer Inc. (US) |
15.2.6.Reddys (India) |
15.2.7.Novartis (Switzerland) |
15.2.8.Sanofi Avemtis (France) |
15.2.9.Eli Lilly (US) |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players